Rallybio CorporationRLYBNASDAQ
Loading
Other Income/Expenses (Net) Over TimeExpanding
Percentile Rank100
3Y CAGR+169.5%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
+169.5%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
19.6x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$24.09M+785.2%
2024$2.72M-37.7%
2023$4.37M+255.1%
2022$1.23M+190.1%
2021$-1.36M-17.8%
2020$-1.16M-1567.1%
2019$79000.00-